Latest news
Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Phase 2a Trial to Refine VCN-01 Therapy for Metastatic Pancreatic Cancer – Minichart - MinichartMinichart · Thu, 06 Aug 2026 18:27:00 GMTTheriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTJordan Larson Camp at VCN - KOLN | Nebraska Local News, Weather, Sports | Lincoln, NEKOLN | Nebraska Local News, Weather, Sports | Lincoln, NE · Mon, 27 Jul 2026 07:00:00 GMT